Sotio

0 followers

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

Employees

201-500

Links


Org chart

Collapse
Pavel Solský
Chief Financial & Commercial Officer
Geoffrey Hodge
CEO, Sotio US
Martin Steegmaier
Chief Scientific Officer
Gaëtan Decherf
CFO At Sotio Biotech AG
Robyn Hunter
Chief Financial Officer

Board & advisors

Kapil Dhingra
Strategic Advisor
Daniel D. Von Hoff
Strategic Advisor
Alise Reicin
Strategic Advisor
Josep Tabernero
Strategic Advisor
Anthony W. Tolcher
Strategic Advisor